Glycobiology Market

Glycobiology Market to Exceed A Value of US$ 1,670.3 Mn by 2024
The term ‘Glycobiology’ was first introduced by Rademacher et al., in 1988, incorporating a
varied array of molecules, collectively termed as ‘glycoconjugates’. Glycobiology is a
branch of ‘Glycosciences’. Glycoscience is interdisciplinary stream having two branches
viz. glycochemistry and glycobiology, which require the involvement of researchers in
various disciplines including but not limited to medical science, pharmaceutical science,
microbiology, biochemistry, material science, and biotechnology. Extensive research related
to carbohydrate molecule in various fields such as marine science and food & beverages
industry is expected to fuel growth of the global glycobiology market. The global market is
expected to reach a value of US$ 1,670.3 Mn by 2024, registering a CAGR of 12.8%
between 2016 and 2024, according to a new report by Persistence Market Research (PMR).
PMR’s report offers market forecast and analysis on the global glycobiology market, while
segmenting the market on the basis of product-type, application, end-user, and region. The
report segments the global glycobiology market into five key regions: North America, Latin
America, Europe, Middle East and Africa (MEA), and Asia Pacific (APAC). According to
PMR regional analysis, North America (including the U.S. and Canada) is the most lucrative
market for glycobiology globally. This region is expected to account for highest market
share over the forecast period (2016–2024) and is expected to exhibit a significantly high
growth rate. Asia Pacific is expected to be the fastest growing market in the global
glycobiology market owing to increasing awareness amongst researchers regarding the
various benefits of research related to carbohydrate molecules and its association with novel
drug development. APAC is estimated to account for around 19.1% revenue share in the
global glycobiology market by the end of 2016. MEA region is also expected to register
significant growth over the forecast period owing to increasing R&D expenditure by
pharmaceutical industries. This region is expected to register a CAGR of 11.0% over the
forecast period.
View and Download TOC of Glycobiology Market Research Report @
https://www.persistencemarketresearch.com/market-research/glycobiology-market/toc
On the basis of product type, PMR has segmented the glycobiology market into instruments,
enzymes, consumables and reagent kits segments. Enzymes product type segment is
expected to dominate the market through the forecast period and is anticipated to be the
most lucrative segment. Enzyme product type segment accounted for 52.6% revenue share
in 2015. Due to high adoption rate of enzymes to conduct various research initiatives, this
segment is expected to witness high incremental opportunity globally.
On the basis of application, PMR has segmented the glycobiology market into drug
discovery and development, therapeutic application, diagnostic application, industrial
application, and others segments. Drug discovery and development application segment is
expected to dominate the market and is anticipated to be the most lucrative segment growing
at a CAGR of 13.4% over the forecast period.
Request and Download Sample Report @
https://www.persistencemarketresearch.com/samples/4769
On the basis of end user, the glycobiology market has been segmented into
biopharmaceutical companies, research laboratories, hospitals, diagnostic centers, contract
research organization, biotechnology industry, academic institutes, and others. PMR
estimates that biopharmaceutical companies end user segment is expected to account for
highest revenue share in the global glycobiology market and is expected to witness fastest
growth over the forecast period. Factors such as increasing demand for novel drug
development, especially for chronic diseases such as cancer and diabetes, is expected to
boost revenue share contribution from the biopharmaceutical companies segment. Research
laboratories segment is also expected to register a significant growth rate during the forecast
period.
The report discusses several factors affecting the global glycobiology market such as
increment in R&D expenditure, key strategies of participant companies, and regional trends.
Some key market participants included in PMR’s global glycobiology market report include
Merck KGaA, Bio-Techne Corporation, Bruker Corporation, Thermo Fisher Scientific, Inc.,
Shimadzu Corporation, Plexera Bioscience LLC, New England Biolabs Inc., Agilent
Technologies, Inc., and ProZyme, Inc.
Buy Full Glycobiology Market Report @
https://www.persistencemarketresearch.com/checkout/4769

The term ‘Glycobiology’ was first introduced by Rademacher et al., in 1988, incorporating a varied array of molecules, collectively termed as ‘glycoconjugates’. Glycobiology is a branch of ‘Glycosciences’

Download Report